Chemical Marker Reporter October 13, 2015 ferghanaadmin Press Release “SCHERING AG; acquired rights for Refludan” Related Posts Reuters "Venture capitalists plough $1 Billion into Euro Biotech" BioPartnering Europe 2001 "Ninth Annual Conference (Part IV) Report" Celularity "New Jersey Startup Celularity Launches With Clinical Assets From Big Name Biotechs"
